LEADER 02133nam  22005654a 450 
001 9910781177103321
005 20230721005838.0
010   $a0-19-770748-3
010   $a1-282-54384-9
010   $a9786612543845
010   $a0-19-970917-3
035   $a(CKB)2550000000010667
035   $a(SSID)ssj0000422375
035   $a(PQKBManifestationID)11315536
035   $a(PQKBTitleCode)TC0000422375
035   $a(PQKBWorkID)10419012
035   $a(PQKB)10844714
035   $a(Au-PeEL)EBL1661315
035   $a(CaPaEBR)ebr10375094
035   $a(CaONFJC)MIL254384
035   $a(OCoLC)923706146
035   $a(MiAaPQ)EBC1661315
035   $a(EXLCZ)992550000000010667
100   $a20071207d2008      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aLupus$b[electronic resource] $ethe essential clinician's guide /$fDaniel J. Wallace
210   $aOxford ;$aNew York $cOxford University Press$d2008
215   $a115 p. $ccol. ill
225 1 $aOxford American rheumatology library
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-19-534319-0 
311   $a0-19-536898-3 
320   $aIncludes bibliographical references (p. 107-109) and index.
327   $aHistory of lupus -- Definitions and classification -- Epidemiology -- Pathogenesis -- Clinical findings-symptoms and signs -- Laboratory and imaging correlates -- Differential diagnosis and disease associations -- Important subsets -- Methods of ascertainment used for clinical trials -- General concepts of treatment -- Medications used to manage lupus -- Economic impact and disability issues -- Prognosis -- Experimental and innovative therapies.
410  0$aOxford American rheumatology library.
606   $aLupus erythematosus
615  0$aLupus erythematosus.
676   $a616.7/72
700   $aWallace$b Daniel J$g(Daniel Jeffrey),$f1949-$01478056
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781177103321
996   $aLupus$93715994
997   $aUNINA